Evidence map›Paper›PMID 41123119›Full record

ArticleCurrent protocols2025

Directed Evolution in Escherichia coli for Novel Ligand-Binding Regulators: Evolving a Progesterone-Responsive Transcription Factor to Bind Cortisol.

Alia Clark-ElSayed, Kaila E Nayvelt, Satoshi Ishida, Simon d'Oelsnitz, Andrew D Ellington

Abstract read
In one paragraph

Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alia Clark-ElSayedDepartment of Molecular Biosciences, University of Texas at Austin, Austin, Texas.ORCID https://orcid.org/0000-0001-9602-4231
Kaila E NayveltDepartment of Molecular Biosciences, University of Texas at Austin, Austin, Texas.ORCID https://orcid.org/0009-0001-0744-2632
Satoshi IshidaDepartment of Molecular Biosciences, University of Texas at Austin, Austin, Texas.ORCID https://orcid.org/0000-0001-5905-8168
Simon d'OelsnitzSynthetic Biology HIVE, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.ORCID https://orcid.org/0000-0001-7512-9157
Andrew D EllingtonDepartment of Molecular Biosciences, University of Texas at Austin, Austin, Texas.ORCID https://orcid.org/0000-0001-6246-5338

Funding

Directed evolution of broadly fungible biosensorsR01GM146093 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Andrew D Ellington · 2023 to 2026
$1.3M
Problem-to-Product Team Entrepreneurship and Active Mentoring (P2P-TEAM) Graduate Training ProgramT32GM139796 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI BRODBELT, JENNIFER S. · 2021 to 2025
$781k
NIGMS NIH HHS R01 GM146093NIGMS NIH HHS T32 GM139796
6 · The paper itself

Abstract

Allosteric transcription factors (aTFs) regulate gene expression in response to small molecules. Engineering aTFs with new ligand specificities expands their utility in environmental monitoring and diagnostics. Here, we present protocols for improving the responsiveness of an aTF, SRTF1, to its non-native ligand, cortisol, based on the SELIS (Seamless Enrichment of Ligand-Inducible Sensors) methodology. First, an aTF library is generated by randomizing the ligand binding pocket. These libraries are then subjected to a selection process to remove protein variants that have lost the ability to repress transcription. The libraries are then plated onto solid media containing the target ligand. The most fluorescent colonies, signifying the most responsive aTFs, are cultured and assayed for the fold change in fluorescence upon induction with the target ligand. Colonies with the highest fold change are cultured, and the plasmid DNA is purified and sequenced. The gene variants are then subcloned into new expression vectors and assayed in a dose-response assay with the target and non-target ligands to have complete characterization of the sensor. Through one round of these protocols, we improved the response of SRTF1 to cortisol by seven-fold; however, the protocols outlined here are applicable to virtually any protein:effector pair. © 2025 The Author(s) Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Library design Basic Protocol 2: Library construction Basic Protocol 3: Selection and screening Basic Protocol 4: Sequencing and validation of hits Support Protocol 1: Predicting protein:effector structure Support Protocol 2: Design of mutagenesis primers Support Protocol 3: Preparation of chemically competent E. coli for single isolate transformations.

Indexed as

Directed Molecular EvolutionEscherichia coliHydrocortisoneProgesteroneTranscription FactorsLigandsProtein BindingSELEX Aptamer TechniqueHydrocortisoneLigandsProgesteroneTranscription Factorsbacterial sensingbiosensor engineeringligandmutagenesisscreeningselection

Identifiers

PMID41123119
PMCPMC12542318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.